Menu
GWAS Study

A multi-cohort genome-wide association study in African ancestry individuals reveals risk loci for primary open-angle glaucoma.

Verma SS, Gudiseva HV, Chavali VRM et al.

38242088 PubMed ID
GWAS Study Type
54779 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

VS
Verma SS
GH
Gudiseva HV
CV
Chavali VRM
SR
Salowe RJ
BY
Bradford Y
GL
Guare L
LA
Lucas A
CD
Collins DW
VV
Vrathasha V
NR
Nair RM
RS
Rathi S
ZB
Zhao B
HJ
He J
LR
Lee R
ZS
Zenebe-Gete S
BA
Bowman AS
MC
McHugh CP
ZM
Zody MC
PM
Pistilli M
KN
Khachatryan N
DE
Daniel E
MW
Murphy W
HJ
Henderer J
KT
Kinzy TG
IS
Iyengar SK
PN
Peachey NS
TK
Taylor KD
GX
Guo X
CY
Chen YI
ZL
Zangwill L
GC
Girkin C
AR
Ayyagari R
LJ
Liebmann J
CC
Chuka-Okosa CM
WS
Williams SE
AS
Akafo S
BD
Budenz DL
OO
Olawoye OO
RM
Ramsay M
AA
Ashaye A
AO
Akpa OM
AT
Aung T
WJ
Wiggs JL
RA
Ross AG
CQ
Cui QN
AV
Addis V
LA
Lehman A
ME
Miller-Ellis E
SP
Sankar PS
WS
Williams SM
YG
Ying GS
CB
Cooke Bailey J
RJ
Rotter JI
WR
Weinreb R
KC
Khor CC
HM
Hauser MA
RM
Ritchie MD
OJ
O'Brien JM
Chapter II

Abstract

Summary of the research findings

Primary open-angle glaucoma (POAG), the leading cause of irreversible blindness worldwide, disproportionately affects individuals of African ancestry. We conducted a genome-wide association study (GWAS) for POAG in 11,275 individuals of African ancestry (6,003 cases; 5,272 controls). We detected 46 risk loci associated with POAG at genome-wide significance. Replication and post-GWAS analyses, including functionally informed fine-mapping, multiple trait co-localization, and in silico validation, implicated two previously undescribed variants (rs1666698 mapping to DBF4P2; rs34957764 mapping to ROCK1P1) and one previously associated variant (rs11824032 mapping to ARHGEF12) as likely causal. For individuals of African ancestry, a polygenic risk score (PRS) for POAG from our mega-analysis (African ancestry individuals) outperformed a PRS from summary statistics of a much larger GWAS derived from European ancestry individuals. This study quantifies the genetic architecture similarities and differences between African and non-African ancestry populations for this blinding disease.

6,003 African American or Afro-Caribbean, African ancestry cases, 5,272 African American or Afro-Caribbean, African ancestry controls

Chapter III

Study Statistics

Key metrics and study information

54779
Total Participants
GWAS
Study Type
Yes
Replicated
5,900 African American or Afro-Caribbean, African ancestry cases, 37,604 African American or Afro-Caribbean, African ancestry controls
Replication Participants
African American or Afro-Caribbean, African unspecified
Ancestry
U.S., Ghana, Nigeria, South Africa
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.